News | July 29, 2025
Astec LifeSciences Q1 FY26 revenue up 30.3%
The company reported consolidated EBITDA loss of Rs. 10.5 crore in Q1 FY26 as compared to loss of Rs. 45.3 crore in the same period last year
The company reported consolidated EBITDA loss of Rs. 10.5 crore in Q1 FY26 as compared to loss of Rs. 45.3 crore in the same period last year
Professor G. D. Yadav is one of India’s most prolific and accomplished engineering-scientists, holding the prestigious National Science Chair from the Government of India
The company has reported total income of Rs. 155.79 crores during the period ended March 31, 2024
Astec LifeSciences has reported total income of Rs. 51.70 crores during the period ended December 31, 2023
Astec LifeSciences has reported total income of Rs. 144.55 crores during the period ended June 30, 2023
He has over two decades of leadership experience as an innovative strategic planner in finance diligence
The consolidated EBITDA stood at Rs. 89.3 crore in FY23 as compared to Rs. 164.5 crore in the same period last year
To enable company to be future-ready by tapping potential in CDMO space
R&D center would be doing a lot of new product generation projects, process optimization, scale-up and product life cycle management work, full synthetic labs, the kilo labs, the process safety labs, and the population lab
He has over 23 years' experience working in leading companies such as Omniactive Health Technologies, Johnson Matthey Chemicals, BASF, Godrej Agrovet Limited & Bharat Petroleum Corporation Limited.
Subscribe To Our Newsletter & Stay Updated
